Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2020 Jan 16;13(2):e007757. doi: 10.1161/CIRCEP.119.007757

Table 1.

Baseline Clinical Characteristics according to the grades of diastolic dysfunction*

DIA_N DIA_I DIA_II DIA_III p - value

No. of patients 23 107 31 49
Age (m ± SD) 52.8 ± 13.0 59.5 ± 9.1 59.4 ± 8.5 58.9 ± 9.9 0.196
Follow-up (years) 8.6 ± 1.1 7.1 ± 1.7 5.7 ± 2.9 3.9 ± 2.4 < 0.001
Female (%) 9 (39.1) 18 (16.8) 4 (12.9) 6 (12.2) 0.032
BMI 24.2 ± 4.4 28.3 ± 4.3 27.3 ± 4.0 28.8 ± 5.0 0.001
ICM 3 (13.0) 60 (56.1) 20 (64.5) 37 (75.5) < 0.001
DCM 1 (4.3) 36 (33.6) 11 (35.5) 12 (24.5) 0.028
Hypertension 14 (60.7) 93 (86.9) 28 (90.3) 45 (91.8) 0.003
DM II 2 (8.7) 30 (28.0) 11 (35.5) 20 (40.8) 0.039
CKD 0 (0) 23 (21.5) 10 (32.2) 16 (32.7) 0.012
Syncope 2 (8.7) 24 (22.4) 5 (16.1) 7 (14.3) 0.349
ICD 2 (8.7) 45 (42.1) 13 (41.9) 20 (40.8) 0.023
CRT P 1 (4.3) 16 (15.0) 2 (6.4) 5 (10.2) 0.350
LVEF ≤35 1 (4.3) 54 (50.5) 25 (80.6) 37 (75.5) < 0.001
ACE/ARB 15 (65.2) 99 (92.5) 31 (100) 47 (96.0) < 0.001
Beta blocker 12 (52.2) 96 (89.7) 26 (83.9) 45 (91.8) < 0.001
Diuretics 4 (17.4) 68 (63.6) 21 (67.7) 35 (71.4) < 0.001
Amiodaron 2 (8.7) 19 (17.8) 3 (9.7) 8 (16.3) 0.557
Sotalol 1 (4.3) 4 (3.7) 3 (9.7) 0 (0.0) 0.181
NYHA I 10 (43.5) 40 (37.4) 9 (29.0) 11 (22.4) 0.193
NYHA II 13 (56.5) 55 (51.4) 16 (51.6) 20 (40.8) 0.543
NYHA III 0 (0) 12 (11.2) 6 (19.4) 18 (36.7) < 0.001
QRS >0.12 s 0 (0) 27 (25.2) 16 (51.6) 23 (46.9) < 0.001
*

n (%); ACE = angiotensin converting enzyme inhibitors, ARB = angiotensin II receptor blockers, BMI = body mass index, CKD = chronic kidney disease, CRT P = cardiac resynchronization therapy pacemaker, DCM = dilated cardiomyopathy, DIA_N = normal diastolic function, DIA_I = impaired relaxation, DIA_II = pseudo-normal pattern, DIA_III = restrictive pattern, DM II = diabetes mellitus 2, ICD = implantable cardioverter/defibrillator, ICM = ischemic cardiomyopathy, LVEF = left ventricular ejection fraction